TY - JOUR
T1 - Alteration in Natural Defense Activity Against NKSusceptible B16 Melanoma Cells after Treatment with Corynebacterium parvum
AU - Karashima, Atsushi
AU - Taniguchi, Kazuto
AU - Yoshikai, Yasunobu
AU - Nomoto, Kikuo
N1 - Funding Information:
Acknowledgements We thank Prof. J. BROUGHTON for valuable comments on the manuscript. This work was in part supported by a Grant-in-Aid to K. NOMOTO from the Ministry of Health and Welfare for a comprehensive 10-year strategy for cancer control and a Grant-in-Aid to Y. YOSHIKAI from the Ministry of Education, Science and Culture, Japan (01015081).
PY - 1991
Y1 - 1991
N2 - We have investigated the effects of administration of C. parvum on host anti-metastatic activity against B16 melanoma H-2L, a natural killer (NK) sensitive clone with a low expression of H-2b. The anti-metastatic activity was estimated by monitoring the following two points. One was the survival ratio at an early stage after an intravenous (iv) inoculation of radiolabeled B16 H-2L cells, the other was the formation of pulmonary metastases after iv injection with the tumor cells. Administration of C. parvum showed a biphasic change in the NK activity of the spleen cells and the peritoneal exudate cells (PEC) in mice. At an early phase (2–3 days) after administration of C. parvum, the NK activity of the spleen cells and PEC was significantly augmented. On the other hand, at a later phase (14 days) after C. parvum administration, the NK activity was deeply depressed. In correlation with NK activity of the mice treated with C. parvum, the anti-metastatic activity of the hosts was augmented in the early phase, whereas a depressed level of anti-metastatic activity was observed in the late phase after administration of C. parvum. These results suggest that the modification of NK activity is a possible basis for modulation of anti-metastatic activity by C. parvum.
AB - We have investigated the effects of administration of C. parvum on host anti-metastatic activity against B16 melanoma H-2L, a natural killer (NK) sensitive clone with a low expression of H-2b. The anti-metastatic activity was estimated by monitoring the following two points. One was the survival ratio at an early stage after an intravenous (iv) inoculation of radiolabeled B16 H-2L cells, the other was the formation of pulmonary metastases after iv injection with the tumor cells. Administration of C. parvum showed a biphasic change in the NK activity of the spleen cells and the peritoneal exudate cells (PEC) in mice. At an early phase (2–3 days) after administration of C. parvum, the NK activity of the spleen cells and PEC was significantly augmented. On the other hand, at a later phase (14 days) after C. parvum administration, the NK activity was deeply depressed. In correlation with NK activity of the mice treated with C. parvum, the anti-metastatic activity of the hosts was augmented in the early phase, whereas a depressed level of anti-metastatic activity was observed in the late phase after administration of C. parvum. These results suggest that the modification of NK activity is a possible basis for modulation of anti-metastatic activity by C. parvum.
UR - http://www.scopus.com/inward/record.url?scp=0025887154&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025887154&partnerID=8YFLogxK
U2 - 10.1016/S0171-2985(11)80206-8
DO - 10.1016/S0171-2985(11)80206-8
M3 - Article
C2 - 1916884
AN - SCOPUS:0025887154
SN - 0171-2985
VL - 182
SP - 414
EP - 424
JO - Immunobiology
JF - Immunobiology
IS - 5
ER -